NEW YORK (GenomeWeb News) — BG Medicine said yesterday that it has withdrawn its registration statement with the US Securities and Exchange Commission for an initial public offering.
 
The Waltham, Mass.-based biomarker and molecular diagnostics maker cited “current market conditions” for its decision not to proceed with the IPO. It did not elaborate on those conditions.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

In Science this week: in vitro generation of human reproductive cells, and more.